Gray Cameron 4
4 · Provention Bio, Inc. · Filed Jul 19, 2018
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Award
Option (right to buy)
2018-07-19+128,981→ 128,981 totalExercise: $4.00Exp: 2028-07-19→ Common Stock, par value $0.0001 (128,981 underlying) - Conversion
Warrant (right to buy)
2018-07-19+144,824→ 144,824 totalExercise: $2.50From: 2017-04-25Exp: 2024-04-25→ Common Stock, par value $0.0001 (144,824 underlying)
Footnotes (3)
- [F1]The option vests in eight equal semi-annual installments commencing on January 19, 2018 and will become fully vested on July 19, 2022.
- [F2]The securities were granted pursuant to the Issuer's 2017 Equity Incentive Plan, effective as of the closing of the Issuer's initial public offering of common stock.
- [F3]As previously reported on reporting person's Form 3 filed on July 3, 2018, upon consummation of the initial public offering of Provention Bio, Inc. (the "Issuer"), which closed on July 19, 2018, each share of Series A Preferred Stock will automatically convert into one share of Common Stock, par value $0.0001 per share ("Common Stock") and the Warrant will automatically convert into a warrant to purchase Common Stock.